Track topics on Twitter Track topics that are important to you
Cerevance has reported positive data from a Phase I clinical trial of its first-in-class, orally-delivered compound in development, CVN424, for...Read More... The post Cerevance reports positive data ...
Boston, MA – April 30, 2019 – Cerevance, a clinical stage biopharmaceutical company advancing new medicines for brain diseases, has successfully completed its Phase 1 clinical trial of CVN...
Dr. Summers to help guide Cerevance’s Drug Discovery and Development Efforts Cerevance, a clinical stage biopharmaceutical company advancing new medicines for brain d...
Biotech, pharma and life science companies make appointments to leadership roles, with additions at Cerevance, Obsidian, KSQ, Lygos, and more.
Former Head of Neuroscience Medicinal Chemistry at AstraZeneca, Roland Bürli, Ph.D., to lead therapeutic development against novel CNS targets Cerevance, a clinical-st...
Dawson to help lead the pursuit of neuronal and glial targets revealed by cell-type-specific profiling of thousands of post-mortem human brain samples Cerevance, a clin...
Results Demonstrate Safety of CVN424 and Enable Initiation of Phase 2 Study in Patients Cerevance, a clinical stage biopharmaceutical company advancing new medicines fo...
CerevanceÂ is a recently formed pharmaceutical company focused on central nervous system diseases. The companyâs strengths include a powerful technology platform, a pipelin...
We have published hundreds of Cerevance news stories on BioPortfolio along with dozens of Cerevance Clinical Trials and PubMed Articles about Cerevance for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cerevance Companies in our database. You can also find out about relevant Cerevance Drugs and Medications on this site too.